Neurology device market seen topping $14 billion by 2030

The market for neurology diagnostic and monitoring devices is projected to rise from $9.32 billion in 2025 to $10.19 billion in 2026, with growth tied to aging populations, rising neurological disease rates and better imaging tools. The report says North America led in 2025 while Asia-Pacific is expected to be the fastest-growing region through 2030.

Why it matters: - Neurology diagnostic and monitoring devices help clinicians detect and track disorders affecting the brain, spinal cord and peripheral nerves. - The market’s growth points to rising demand for earlier diagnosis, real-time monitoring and more personalized care for conditions such as epilepsy, stroke, Alzheimer’s disease and multiple sclerosis. - A larger installed base of these devices can improve hospital workflows and expand access to non-invasive and portable neurological testing.

What happened: - The Business Research Company released a 2026 market report on neurology diagnostic and monitoring devices. - The report projects the market will grow from $9.32 billion in 2025 to $10.19 billion in 2026. - The report forecasts the market will reach $14.38 billion by 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report is available as a free sample and a full version online: Download the sample report and view the full report.

The details: - The report pegs 2025-26 growth at a 9.3% compound annual growth rate. - It projects a 9.0% CAGR through 2030. - Historical growth was driven by higher rates of neurological disorders, better imaging infrastructure, stronger EEG and MRI technology, more hospital diagnostic procedures and an aging global population. - Future growth is expected to come from remote patient monitoring, more neurology centers, greater awareness of brain health, diagnostic imaging innovation and higher investment in neurological research. - Emerging trends include portable devices, earlier disease detection, non-invasive diagnostics, remote monitoring solutions and multimodal imaging. - The report says neurology diagnostic and monitoring devices are used to evaluate neurological function and support timely, accurate diagnoses. - The devices are designed to assist in identifying and monitoring epilepsy, stroke, Alzheimer’s disease and multiple sclerosis. - The report also includes market attractiveness scoring, total addressable market analysis, company scoring matrices, Excel dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - Rising neurodegenerative disease prevalence is the clearest demand signal in the report. - The report links that trend to aging populations, longer life expectancies and greater exposure to environmental and genetic risk factors. - In April 2025, the Alzheimer’s Association reported that more than 7 million Americans were living with Alzheimer’s and projected that figure would nearly double to 13 million by 2050. - The mix of portable, non-invasive and remote-monitoring tools suggests the market is shifting toward care outside traditional hospital settings. - The emphasis on multimodal imaging and early detection suggests competition will likely center on devices that combine speed, accuracy and lower patient burden.

What's next: - The report expects continued expansion through 2030 as health systems invest in better neurological diagnostics and monitoring. - Adoption of remote monitoring and portable devices is likely to deepen as clinicians look for faster and less invasive ways to track disease progression. - Growth in Asia-Pacific could accelerate as more neurology centers open and awareness of brain health rises. - The company provided contact details for its report team and offered updated 2026 report features for buyers seeking additional market data.